IM Cannabis (IMCC) Capital Expenditures (2020 - 2026)

IM Cannabis' Capital Expenditures history runs 7 years deep, the most recent figure standing at -$3646.0 for Q1 2026.

• In Q1 2026, Capital Expenditures changed N/A year-over-year to -$3646.0; the TTM figure through Mar 2026 stood at $210375.7 (changed N/A YoY), while the FY2025 annual figure was $9322.1, down 91.82% from the prior year.
• Capital Expenditures was -$3646.0 for Q1 2026 at IM Cannabis, down from $15058.8 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.9 million in Q3 2022 to a low of -$2.2 million in Q4 2022.
• Historically, Capital Expenditures has averaged -$42157.1 across 5 years, with a median of -$20101.5 in 2024.
• Biggest YoY gain for Capital Expenditures was 276.02% in 2022; the steepest drop was 135.26% in 2022.
• A 5-year view of Capital Expenditures shows it stood at -$2.2 million in 2022, then soared by 138.35% to $832963.3 in 2023, then tumbled by 75.76% to $201869.5 in 2024, then tumbled by 92.54% to $15058.8 in 2025, then tumbled by 124.21% to -$3646.0 in 2026.
• The last three Capital Expenditures figures came in at -$3646.0 (Q1 2026), $15058.8 (Q4 2025), and -$2906.5 (Q3 2025), per Business Quant data.